✦ LIBER ✦

Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis

✍ Scribed by Pilcer, Gabrielle; De Bueger, Véronique; Traina, Karl; Traore, Hamidou; Sebti, Thami; Vanderbist, Francis; Amighi, Karim

Book ID: 120274176
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 914 KB
Volume: 451
Category: Article
ISSN: 0378-5173
DOI: 10.1016/j.ijpharm.2013.04.069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic Review of Colistimethate Sodi

Systematic Review of Colistimethate Sodium Dry Powder and Tobramycin Dry Powder Antibiotics for Pseudomonas Aeruginosa Lung Infection in Cystic Fibrosis

✍ Harnan, S.E.; Uttley, L.; Cantrell, A.; Taylor, C.J.; Walshaw, M.; Brownlee, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Inhalable Antibiotic Delivery Using a Dr

Inhalable Antibiotic Delivery Using a Dry Powder Co-delivering Recombinant Deoxyribonuclease and Ciprofloxacin for Treatment of Cystic Fibrosis

✍ Yan Yang; Michael D. Tsifansky; Chia-Jung Wu; Hae In Yang; Gudrun Schmidt; Yoon 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 282 KB

Dry powder inhalation of antibiotics in

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2: Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients

✍ P.P.H Le Brun; A.H de Boer; G.P.M Mannes; D.M.I de Fraı̂ture; R.W Brimicombe; D. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 French ⚖ 133 KB

The Cost-Effectiveness of Dry Powder Ant

The Cost-Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas Aeruginosa in Patients with Cystic Fibrosis

✍ Tappenden, P.; Harnan, S.; Uttley, L.; Mildred, M.; Taylor, C.J.; Brownlee, K.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Systematic review of the dry powder inha

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis

✍ Uttley, L.; Harnan, S.; Cantrell, A.; Taylor, C.; Walshaw, M.; Brownlee, K.; Tap 📂 Article 📅 2013 🏛 European Respiratory Society 🌐 English ⚖ 427 KB

This systematic review evaluated evidence for two dry powder formulations, colistimethate sodium and tobramycin, for the treatment of chronic __Pseudomonas aeruginosa__ in cystic fibrosis, as part of the UK national recommendation process for new technologies. Electronic bibliographic databases were

In vitro lung delivery of bacteriophages

In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis

✍ L. Golshahi; K.H. Lynch; J.J. Dennis; W.H. Finlay 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB